Characteristics of ischaemic stroke associated with COVID-19

Rahma Beyrouti, Matthew E Adams, Laura Benjamin, Hannah Cohen, Simon F Farmer, Yee Yen Goh, Fiona Humphries, Hans Rolf Jäger, Nicholas A Losseff, Richard J Perry, Sachit Shah, Robert J Simister, David Turner, Arvind Chandratheva, David J Werring, Rahma Beyrouti, Matthew E Adams, Laura Benjamin, Hannah Cohen, Simon F Farmer, Yee Yen Goh, Fiona Humphries, Hans Rolf Jäger, Nicholas A Losseff, Richard J Perry, Sachit Shah, Robert J Simister, David Turner, Arvind Chandratheva, David J Werring

No abstract available

Keywords: infectious diseases; stroke.

Conflict of interest statement

Competing interests: DJW has received personal fees from Bayer, Alnylam and Portola, outside the submitted work

References

    1. Chen N, Zhou M, Dong X, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020;395:507–13. 10.1016/S0140-6736(20)30211-7
    1. Tang N, Li D, Wang X, et al. . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–7. 10.1111/jth.14768
    1. Mao L, Jin H, Wang M, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020. (published Online First: 2020/04/11). 10.1001/jamaneurol.2020.1127
    1. Zhang Y, Xiao M, Zhang S, et al. . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020. (published Online First: 2020/04/09).
    1. Thachil J, Tang N, Gando S, et al. . ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Journal of Thrombosis and Haemostasis;n/a(n/a).

Source: PubMed

3
Se inscrever